Security key
H17182108
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 9,318,273
- Total 13F value
- $515,428,470
- Share change
- -629,188
- SEC-reported price per share
- $55.32
- Number of holders
- 185
- Value change
- -$34,758,853
- Number of buys
- 82
- Number of sells
- 61
- Shares outstanding
- 97,024,000
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2026
Institutions
185
Top holders
10
CRSP full security history
Ownership snapshot
Full 13F holder table
CRISPR Therapeutics AG SEC filings
CRISPR Therapeutics AG company facts
Broader feeds
Ownership snapshot
Top reported holders of CRSP - CRISPR Therapeutics AG - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ARK Investment Management...
Disclosed value leader
ARK Investment Management...
Comparable rows
5/15
Latest evidence
30 Jun 2026
13D/G
13F
Lead comparable stake: 12%
10 rows are not safely comparable across share classes.
13D/G row: ARK Investment Management LLC
Showing 1-6 of 15 holder rows.
Quick read
ARK Investment Management LLC leads the comparable SEC ownership view at 12%.
5 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ARK Investment Management LLC's linked filing trail.
Comparable ownership
Top 5
ARK Investment Management LLC
12%
BlackRock, Inc.
8.3%
ORBIS INVESTMENT MANAGEMENT LTD
5.6%
Capital World Investors
5.1%
Capital International Investors
1.2%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ARK Investment Management LLC |
13D/G
13F
Company
|
12%
Reported 13D/G
· 31 Mar 2026
|
$538,189,046
11,313,623 shares
|
+$72,622,740 | 31 Mar 2026 |
| BlackRock, Inc. |
13F
13D/G
Company
|
8.3%
Reported 13D/G
· 30 Jun 2026
|
$455,353,197
8,348,977 shares
|
— | 30 Jun 2026 |
| ORBIS INVESTMENT MANAGEMENT LTD |
13D/G
|
5.6%
Reported 13D/G
· 30 Jun 2026
|
$289,868,902
5,433,344 shares
|
-$35,042,948 | 30 Jun 2026 |
| Capital World Investors |
13D/G
13F
Company
|
5.1%
Reported 13D/G
· 31 Mar 2026
|
$270,280,537
4,929,428 shares
|
$0 | 31 Mar 2026 |
| Capital International Investors |
13F
13D/G
Company
|
1.2%
Reported 13D/G
· 30 Jan 2026
|
$69,178,918
1,268,407 shares
|
— | 30 Jun 2026 |
| Orbis Allan Gray Ltd |
13F
Company
|
—
denominator unverified
|
$297,197,241
5,449,161 shares
|
— | 30 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
185
Shares
9,318,273
Rows available
185
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2026 vs Q2 2026 Across Filers
Q2 2026 holders
519
Q3 2026 holders
185
Holder diff
-334
| Investor | Q2 2026 Shares | Q3 2026 Shares | Share Diff | Share Chg % | Q2 2026 value | Q3 2026 value | Value change | Value Chg % |
|---|